Clinical Trial

Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma

Name: Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma — clinical trial record (NCT06467097)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SABLOR

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate whether incorporating locoregional radiotherapy in the treatment of oligometastatic renal cell carcinoma, including inductive oligometastases, along with standard systemic therapy, contributes to improved progression-free survival rates for patients.

Trial Details

NCT Number	NCT06467097
Lead Sponsor	Samsung Medical Center
Conditions	Kidney Neoplasm
Enrollment	88 participants
Start Date	2024-04-16
Primary Completion	2031-02-13 (estimated)
Study Completion	2031-02-13 (estimated)
Updated on ClinicalTrials.gov	2024-06-20